Ozempic face: lost volume, loose skin, and what helps
"Ozempic face" is a nickname for the hollow cheeks and loose skin that can follow fast weight loss, from a GLP-1 medicine or anything else. Lost volume calls for a physician or surgeon (filler, fat grafting), which Karisma does not offer. Mild loose skin is a device question: XERF is $1,500 a session, with no data yet on post-GLP-1 skin.
Published · Written by Kay Woodson · Results vary.This page says nothing about your medicine
Karisma is an esthetics studio. Kay does not advise on Ozempic, Wegovy, Mounjaro or any other prescription, its dose, or whether to start or stop it. Those questions belong with the clinician who prescribes it. This page is about the skin.
What is Ozempic face?
Cleveland Clinic describes it as the changes in the face that can come with rapid weight loss: a gaunt look, sunken cheeks, new wrinkles and loose skin on the face and neck. The term became popular on social media. It is not a medical term.
It is not a side effect of the drug itself. It is a side effect of losing weight fast. The same changes can follow bariatric surgery or a strict diet. GLP-1 medicines get the name because they can bring people to a weight they have not seen in years, quickly.
Why does the face change after weight loss?
Cleveland Clinic's endocrinologist points to three things.
- Fat leaves the face. The fat just under the skin keeps the face full. When it goes fast, cheeks and temples hollow and skin has less to rest on.
- Aging speeds up. Everyone loses facial fat with age. Rapid weight loss can make the same change happen in months.
- Skin loses spring. Rapid weight loss lowers collagen and elastin, the proteins that keep skin firm and stretchy.
The faster the loss, the more likely the face shows it. Cleveland Clinic's endocrinologist, Dr. Vinni Makin, points to slower loss, about 1 to 2 pounds a week; set your pace with your prescriber. Older adults are more likely to notice the change because they start with less facial fat.
Volume or looseness? Match the fix to the problem
Most faces after big weight loss show some of both. The options below are the ones Cleveland Clinic and plastic surgeons name. Several are not offered at Karisma, and this table says so.
| What you see | What is going on | Options | At Karisma |
|---|---|---|---|
| Hollow cheeks or temples | Lost fat, lost volume | Dermal fillers, fat grafting | Not offered |
| Thinner lips | Lost volume | Lip filler | Not offered |
| Mild loose skin on the jaw or neck | Skin has lost firmness | Radiofrequency skin tightening, microneedling | XERF, $1,500 a session. No microneedling |
| Heavy jowls or folds of skin | Extra skin | Facelift, neck lift | Not offered. See a plastic surgeon |
| Dull, dry surface and fine lines | Surface changes | Daily sunscreen and a skin care routine | Facials from $125 |
Karisma prices from GlossGenius, October 2026.
Does Ozempic face go away?
Not on its own. Cleveland Clinic is clear that it will not fade with time. If weight comes back, the face may look fuller again. If you keep the weight off, the changes tend to stay.
Cleveland Clinic also notes that it brings no negative health effects and needs no treatment unless you want it. Treating it is a choice, not a need.
What plastic surgeons are seeing
The American Society of Plastic Surgeons published its 2025 statistics on September 1, 2026. Facial fat grafting, which moves your own fat into the face, grew 39 percent, the largest one-year gain of any procedure it tracks. Neck lifts rose 21 percent and facelifts 13 percent. 82 percent of its member surgeons said they had GLP-1 related consultation requests.
ASPS adds a fair warning: those numbers show more conversations, not proof that GLP-1 medicines caused any one trend. Its president said significant weight loss, "regardless of how it is achieved," can leave excess skin and lost facial volume that diet and exercise cannot fix.
Where XERF fits, and where it does not
XERF is a radiofrequency device used to help improve the appearance of loose skin. It is not a filler and it cannot put back fat that is gone. If your main change is hollowness, volume treatments from a physician or surgeon are the closer match. If it is mild looseness along the jaw or neck, XERF may be worth a consultation. Results vary, and published XERF data are still two small face and neck studies, 39 people and 16 women, neither about weight loss. The larger one enrolled skin types I to IV only.
Timing is worth asking about. In Cynosure's own XERF trial, participants agreed not to take weight-loss medicines or treatments and to keep their diet and exercise the same during the study, so results would be easier to read. That was a research rule, not medical advice. [TO CONFIRM: Kay's guidance on timing XERF for clients whose weight is still changing, Kay]
At Karisma, the $150 consultation covers your skin and goals and is credited to a first $1,500 session. Bring your questions about the skin; keep the medicine questions for your prescriber.
Questions about Ozempic face
Is Ozempic face only caused by Ozempic?
No. Cleveland Clinic says any rapid weight loss can cause it, including bariatric surgery or a strict diet. Other GLP-1 medicines such as Wegovy and Mounjaro are linked to it for the same reason: fast loss.
Can you prevent Ozempic face?
Cleveland Clinic says faster weight loss makes facial changes more likely. How fast to lose weight is a question for your prescriber, not an esthetician.
Can skin tightening fix Ozempic face?
Only in part. Tightening devices target loose skin. They do not replace lost volume, so a face that lost both may need more than one approach.
Is it safe to get XERF while taking a GLP-1 medicine?
There is no published study on that combination. The maker's trial kept weight-loss medicines out of the study period. Tell the provider about every medicine you take, and ask your prescriber too.
- Ozempic face: what it is and how to avoid it, Cleveland Clinic Health Essentials, March 5, 2025
- 2025 Procedural Statistics Report press release, American Society of Plastic Surgeons, September 1, 2026
- Safety and Efficacy Evaluation of the XERF Device, ClinicalTrials.gov NCT07585591, eligibility criteria, checked October 29, 2026
- Weiss RA et al. Dual-frequency noninvasive monopolar radiofrequency for facial laxity, a prospective multicenter study. Cureus, March 2, 2026
- Erlich, Dahan, Wolf. Retrospective evaluation of XERF. Lasers in Medical Science, August 18, 2026
- FDA 510(k) K251327, XERF, Lutronic Corporation, summary, decision August 11, 2025
